EAM
ZLAB icon

Exome Asset Management’s Zai Lab ZLAB Stock Holding History

Exome Asset Management’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-86,700
Closed -$1.5M – 81
2024
Q2 		$1.5M Buy
86,700
+21,400
+33% +$376K 1.34% 33
2024
Q1 		$1.05M Buy
+65,300
New +$1.38M 0.9% 45

Other funds holding ZLAB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Exome Asset Management's ZLAB Position: Q3 2024 in Review

Exome Asset Management sold out of Zai Lab (ZLAB) in Q3 2024, closing a stake of 86,700 shares — an estimated $1.5M sold.

Exome Asset Management first reported a position in ZLAB in Q1 2024 and held it in 2 quarters. The position peaked at $1.5M in Q2 2024. 104 funds tracked by Wall St. Rank hold ZLAB as of Q3 2024.

  • Exome Asset Management reported no remaining Zai Lab position as of Q3 2024 after selling out during the quarter.
  • Exome Asset Management sold 86,700 Zai Lab shares in Q3 2024, an estimated $1.5M.
  • Exome Asset Management first reported a position in Zai Lab in Q1 2024 and held it in 2 quarters.
  • Exome Asset Management's Zai Lab position peaked at $1.5M in Q2 2024.
  • 104 funds tracked by Wall St. Rank held Zai Lab as of Q3 2024.

Based on Exome Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.